![Olivia Ware](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: - $ al 31/08/2026
Olivia C.
Ware is currently an Independent Director at Contineum Therapeutics, Inc. since 2024.
Formerly, Ms. Ware was a Director at Ambrx, Inc. Independent Director roles were held at Ambrx Biopharma Cayman, Inc. from 2021 to 2022, Revance Therapeutics, Inc. from 2021 to 2025, and Arcellx, Inc. from 2022 to 2026.
Other former positions include Senior VP-US Market & Franchise Development at Proteus Digital Health, Inc. from 2018 to 2019, Senior Vice President-BTK Franchise at Principia Biopharma, Inc. from 2019 to 2021, and Chief Commercial Officer at LadRx Corp.
from 2016 to 2017.
Education includes an undergraduate degree from Davidson College and an MBA from The University of North Carolina at Chapel Hill.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 26/06/2026 | 0 ( -.--% ) | - $ | 31/08/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| CONTINEUM THERAPEUTICS, INC. | Director/Miembro de la Junta | 01/03/2024 |
| Empresas | Cargo | Fin |
|---|---|---|
| ARCELLX, INC. | Director/Miembro de la Junta | 28/04/2026 |
| REVANCE THERAPEUTICS, INC. | Director/Miembro de la Junta | 04/02/2025 |
Ambrx Biopharma, Inc.
 Ambrx Biopharma, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biologics company | Director/Miembro de la Junta | 01/06/2022 |
| PRINCIPIA BIOPHARMA INC. | Corporate Officer/Principal | 01/03/2021 |
Proteus Digital Health, Inc.
 Proteus Digital Health, Inc. Pharmaceuticals: MajorHealth Technology Develops medicine products and therapeutic devices | Corporate Officer/Principal | 01/01/2019 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 10 |
|---|---|
LadRx Corp.
 LadRx Corp. BiotechnologyHealth Technology Operates as a biopharmaceutical research and development oncology company | Health Technology |
Proteus Digital Health, Inc.
Proteus Digital Health, Inc. Pharmaceuticals: MajorHealth Technology Develops medicine products and therapeutic devices | Health Technology |
Revance Therapeutics, Inc.
 Revance Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops drugs for esthetics, skincare and therapeutics | Health Technology |
Principia Biopharma, Inc.
 Principia Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a R&D driven and AI-powered biopharma company | Health Technology |
Davidson College
 Davidson College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of North Carolina at Chapel Hill
 The University of North Carolina at Chapel Hill Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ambrx, Inc.
 Ambrx, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company | Health Technology |
Arcellx, Inc.
 Arcellx, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company focused on reimagining cell therapy through the development of innovative immunotherapies | Health Technology |
Pipeline Therapeutics, Inc.
 Pipeline Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company that develops novel, oral small molecule therapies for neuroscience, inflammation and immunology indications | Health Technology |
Ambrx Biopharma, Inc.
Ambrx Biopharma, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biologics company | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
